Clinical Trial Update: Study of Induction Treatment With Velcade and Dexamethasone for Previously Untreated Patients With Multiple Myeloma and Renal Failure [Phase 2]

View source ↗

Summary

Phase 2 study evaluating induction therapy with Velcade (bortezomib) and dexamethasone in previously untreated multiple myeloma patients with renal failure. The…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• DEXAMETHASONE (Dexamethasone)
• Velcade (bortezomib)

Snippet

Sponsor: PETHEMA Foundation | Conditions: Multiple Myeloma | Phase 2 | Status: COMPLETED